In plain language. Written by scientists. uniQure reports that after 4 years, people given high-dose AMT-130 continue to show signs of slower HD progression, providing hope for their recent regulatory ...
Four years after a single treatment, the high-dose AMT-130 group continues to show encouraging signs of slower HD progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results